Memphasys Ltd has released a press release.
2024 Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Memphasys
- Felix TM System Sales Orders Accelerate in Japan
- AI-Port Update - Spring Field Trial Yields Positive Results
- Vitrolife distribution agreement expands into Canada and NZ
- $4.2m raise to pursue commercial opportunities with Felix
- Board and executive transition and capital raise
Later from Memphasys
- Felix Japanese trial provides sperm preparation benefits
- Investor Presentation
- Dr David Ali appointed full-time Chief Executive Officer
- Animal activity update - oxidative stress measurement system
- Felix sales clinical trial and Oxidative Stress devel update
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys